Inventor · disambiguated record
Xin Xiao Zheng
Also filed as: ZHENG XIN · ZHENG XIN X · ZHENG XIN XIAO
10 granted patents·12 pending applications·277 citations·filing 1994–2024
92Inventor score
Files withBETH ISRAEL HOSPITAL10BRIGHAM & WOMENS HOSPITAL6ZHENG XIN X2HUMANWELL PHARMACEUTICAL US INC1Humanwell Pharmaceutical US1
Top patents by PatentIndex Score
22 records- 0190US6770272B2Treatment of diabetesBETH ISRAEL HOSPITAL·Filed 2002·Granted Aug 3, 2004·24 cites·9 claims
- 0287US6797263B2Compositions and methods for achieving immune suppressionBETH ISRAEL HOSPITAL·Filed 2001·Granted Sep 28, 2004·33 cites·20 claims
- 0387US6403077B1Treatment regimes featuring an IL-10-containing chimeric polypeptideBETH ISRAEL HOSPITAL·Filed 1997·Granted Jun 11, 2002·89 cites·6 claims
- 0486US8329660B2Tim-3 ligands and methods thereofKUCHROO VIJAY K·Filed 2004·Granted Dec 11, 2012·33 cites·8 claims
- 0586US6410008B1Chimeric IL-10 proteins and uses thereofBETH ISRAEL HOSPITAL·Filed 1994·Granted Jun 25, 2002·48 cites·7 claims
- 0684US7347995B2Compositions and methods for achieving immune suppressionBETH ISRAEL HOSPITAL·Filed 2004·Granted Mar 25, 2008·22 cites·17 claims
- 0782US7741271B2Methods of modulating immune responses by modulating tim-1, tim-2 and tim-4 functionBRIGHAM & WOMENS HOSPITAL·Filed 2005·Granted Jun 22, 2010·6 cites·12 claims
- 0882US7579439B2Modulation of IL-2- and IL-15-mediated T cell responsesBETH ISRAEL HOSPITAL·Filed 2003·Granted Aug 25, 2009·16 cites·10 claims
- 0976US7018626B2Chimeric IL-10BETH ISRAEL HOSPITAL·Filed 2002·Granted Mar 28, 2006·4 cites·15 claims
- 1075US9346876B2TIM-3 ligands and methods of modulating immune responsesBRIGHAM & WOMENS HOSPITAL·Filed 2014·Granted May 24, 2016·2 cites·7 claims
- 1165US2005058624A1Chimeric IL-10 proteins and uses thereofBETH ISRAEL HOSPITAL·Filed 2004·Application pending·0 cites
- 1261US2005031611A1Transplant tolerance by costimulation blockade and T-cell activation-induced apoptosisBETH ISRAEL HOSPITAL·Filed 2004·Application pending·0 cites
- 1360US2024174693A1Somatostatin receptor subtype 4 (sstr4) agonists and their applicationsHumanwell Pharmaceutical US·Filed 2023·Application pending·0 cites
- 1460US2008089894A1Transplant tolerance by costimulation blockade and T-cell activation-induced apoptosisSTROM TERRY B·Filed 2007·Application pending·0 cites
- 1560US2006246032A1Chimeric IL-10BETH ISRAEL HOSPITAL·Filed 2006·Application pending·0 cites
- 1658US2006057102A1Mutant interleukin-15-containing compositions and suppression of an immune responseZHENG XIN X·Filed 2005·Application pending·0 cites
- 1758US2015079085A1Methods of modulating immune responses by modulating tim-1, tim-2 and tim-4 functionBRIGHAM & WOMENS HOSPITAL·Filed 2014·Application pending·0 cites
- 1856US2024317745A1Sigma-1 receptor antagonists and their applicationsHUMANWELL PHARMACEUTICAL US INC·Filed 2024·Application pending·0 cites
- 1954US2013195895A1Methods of modulating immune responses by modulating tim-1, tim-2 and tim-4 functionBRIGHAM & WOMENS HOSPITAL·Filed 2013·Application pending·0 cites
- 2050US2013183688A1Tim-3 ligands and methods thereofBRIGHAM & WOMENS HOSPITAL·Filed 2012·Application pending·0 cites
- 2148US2006057680A1Mutant interleukin-15 polypeptidesZHENG XIN X·Filed 2005·Application pending·0 cites
- 2248US2011045002A1Methods of modulating immune responses by modulating tim-1, tim-2 and tim-4 functionBRIGHAM & WOMENS HOSPITAL·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Xin Xiao Zheng files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →